Follow
Targeted Therapy
Targeted Therapy: one of the major modalities of medical treatment for cancer, others being hormonal therapy and cytotoxic chemotherapy.
What's Popular in Targeted Therapy
-
MAR 08, 2024Drug Discovery & Development
This study unraveled an exciting and unexplored facet of MS treatmentWritten By: Amielle MorenoMAR 06, 2024Health & Medicine
Gone are the days when therapies for medical conditions were based solely on statistical data of the broad population, l ...Sponsored By: ESSERT RoboticsMAR 05, 2024Drug Discovery & Development
eEF1A's surprising tumor-suppressive role in breast cancer, offering a new upstream targetWritten By: Amielle MorenoMAR 04, 2024Cell & Molecular Biology
With astonishing advances in molecular biology, cell and gene therapies represent a new class of pharmaceuticals availab ...Sponsored By: Single Use SupportFEB 29, 2024Immunology
Myeloid cells are a population of cells classified to denote a specific lineage. “Myeloid” specifically refe ...Written By: Brian G. Morreale
MAR 08, 2024
Drug Discovery & Development
This study unraveled an exciting and unexplored facet of MS treatment
Written By:
Amielle Moreno
MAR 06, 2024
Health & Medicine
Gone are the days when therapies for medical conditions were based solely on statistical data of the broad population, l
...
Sponsored By:
ESSERT Robotics
MAR 05, 2024
Drug Discovery & Development
eEF1A's surprising tumor-suppressive role in breast cancer, offering a new upstream target
Written By:
Amielle Moreno
MAR 04, 2024
Cell & Molecular Biology
With astonishing advances in molecular biology, cell and gene therapies represent a new class of pharmaceuticals availab
...
Sponsored By:
Single Use Support
FEB 29, 2024
Immunology
Myeloid cells are a population of cells classified to denote a specific lineage. “Myeloid” specifically refe
...
Written By:
Brian G. Morreale
FEB 29, 2024
Immunology
Jennifer Doudna and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in g
...
Written By:
Brian G. Morreale
FEB 29, 2024
Microbiology
Long COVID is a pressing public health issue. Millions of people experienced an acute infection with the pandemic virus
...
Written By:
Carmen Leitch
FEB 22, 2024
Immunology
The US Food and Drug Administration (FDA) recently approved a tumor-infiltrating lymphocyte (TIL) therapy referred to as
...
Written By:
Brian G. Morreale
FEB 15, 2024
Immunology
There are various ways to treat cancer. The gold standard has been chemotherapy for over 50-years. However, treatment wi
...
Written By:
Brian G. Morreale
-
MAR 26, 2024 | 7:00 PMC.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...Speaker: Steven Melnick. Ph.D., M.D. , Dr. David Mancuso, Pharm.D. CPh , MSPMSponsored By: Thermo Fisher ScientificMAR 26, 2024 | 8:00 AMC.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...Speaker: Steven Melnick. Ph.D., M.D. , Dr. David Mancuso, Pharm.D. CPh , MSPMSponsored By: Thermo Fisher ScientificDEC 14, 2023 | 10:00 AMC.E. CREDITS
Over the course of the COVID-19 pandemic, there has been a dramatic increase in the number and type of diagnostic tests for respiratory viruses. These include targeted molecular assays, smal...DEC 05, 2023 | 8:00 AM
CGX10 Cell Isolation System: Introduction, Utility, and Assessment in a GMP-grade Environment for Multiparametric Cell Sorting A future of long-term, minimally toxic immunotherapy personaliz...NOV 30, 2023 | 12:00 PMC.E. CREDITS
Pathology Perspective: Discover the critical need for genomic testing in cancer and explore the differences between traditional tissue biopsies and liquid genomic profiling. We'll dive i...Speaker: Dr. Shuko Harada , Dr. Aakash Desai, MBBS, MPHPresented at: Precision Medicine in Solid Tumors
MAR 26, 2024 | 7:00 PM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
Speaker:
Steven Melnick. Ph.D., M.D.
, Dr. David Mancuso, Pharm.D. CPh , MSPM
Sponsored By: Thermo Fisher Scientific
MAR 26, 2024 | 8:00 AM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
Speaker:
Steven Melnick. Ph.D., M.D.
, Dr. David Mancuso, Pharm.D. CPh , MSPM
Sponsored By: Thermo Fisher Scientific
DEC 14, 2023 | 10:00 AM
C.E. CREDITS
Over the course of the COVID-19 pandemic, there has been a dramatic increase in the number and type of diagnostic tests for respiratory viruses. These include targeted molecular assays, smal...
DEC 05, 2023 | 8:00 AM
CGX10 Cell Isolation System: Introduction, Utility, and Assessment in a GMP-grade Environment for Multiparametric Cell Sorting A future of long-term, minimally toxic immunotherapy personaliz...
NOV 30, 2023 | 12:00 PM
C.E. CREDITS
Pathology Perspective: Discover the critical need for genomic testing in cancer and explore the differences between traditional tissue biopsies and liquid genomic profiling. We'll dive i...
Speaker:
Dr. Shuko Harada
, Dr. Aakash Desai, MBBS, MPH
Presented at: Precision Medicine in Solid Tumors
NOV 29, 2023 | 9:00 AM
Tumor genomic profiling can be complicated, especially for diseases that commonly have multiple different genomic biomarkers of interest, such as non-small cell lung cancer (NSCLC) and color...
NOV 09, 2023 | 6:00 AM
In this talk we will explore the application of Multiplexed Error-Robust Fluorescence in situ Hybridization (MERFISH) technology to decode spatially regulated disease drivers in human heart...
NOV 07, 2023 | 10:00 AM
In the last 5 years, the US Food and Drug Administration has approved 4 anti-CD19 chimeric antigen receptor T cell (CART19) products for relapsed/refractory B cell lymphomas and leukemia. Ho...
NOV 01, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
-
Labroots is pleased to announce the 4th annual event in the Immuno-Oncology Virtual Event Series taking place on April 30th, 2025. Immuno-Oncology is at the forefront of groundbreaking resea...
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...NOVEMBER 1, 2024
Featuring emerging trends, new applications, and workflow solutions-Where Solutions Deliver Results!...OCT 02, 2024 | 7:00 AM PDTC.E. CREDITS
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
DXRX LabTalks are a dynamic webinar series led by the foremost experts within the DXRX Lab Network. These sessions are designed to connect you with cutting-edge knowledge and provide invalua...
Labroots is pleased to announce the 4th annual event in the Immuno-Oncology Virtual Event Series taking place on April 30th, 2025. Immuno-Oncology is at the forefront of groundbreaking resea...
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
NOVEMBER 1, 2024
Featuring emerging trends, new applications, and workflow solutions-Where Solutions Deliver Results!...
OCT 02, 2024
| 7:00 AM PDT
C.E. CREDITS
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
DXRX LabTalks are a dynamic webinar series led by the foremost experts within the DXRX Lab Network. These sessions are designed to connect you with cutting-edge knowledge and provide invalua...
APR 30, 2024
| 5:00 AM PDT
C.E. CREDITS
LabRoots is pleased to announce the inauguration of the Immuno-Oncology Virtual Event taking place on May 1, 2024. Immuno-Oncology is considered by some to be one of the most promising area...
JUN 12, 2024
| 1:00 PM PDT
C.E. CREDITS
Precision medicine in solid tumors is transforming the testing and treatment of cancer. You can be part of this exciting field by joining our one-day virtual event. Some of the highlights of...
APR 18, 2024
C.E. CREDITS
Stago EdVantage Virtual University is an educational platform that demystifies hemostasis testing with on-demand webinars and a virtual exhibit hall that ......
OCT 03, 2023
| 5:30 AM PDT
C.E. CREDITS
Labroots is pleased to announce the 11th Annual Event in the Cancer Research & Immuno-Oncology Week Virtual Event Series! This 3 day event will take place on October 3-5, 2023....